Cancer research investment

  • Charts and Tables

    Charts and Tables

    Figure 6.6

    Comparison of the relative burden of disease to the relative investment in research by disease site: Distribution of cancer research investment (2013), new cancer cases (2012) and cancer deaths (2011), by disease site, Canada

    “Other” refers to remaining primary types of cancer listed in International Classification of Diseases for

    Oncology-3. Included are all other invasive types and in situ for bladder.

    Data source: For cancer research investment: Canadian Cancer Research Alliance database.

    Data source for new cancer cases: Statistics Canada, Canadian Cancer Registry.

    Data source for cancer deaths: Statistics Canada, Vital Statistics Death Database.

    Source: CANSIM Table 103-0550 for 2012 cancer cases, CANSIM Table 102-0552 for 2011 cancer deaths.

    Data Table

    Disease SiteCancer Research Investment (%)New Cancer Cases (%)Cancer Deaths (%)
    Breast25.713.26.9
    Prostate12.711.95.1
    Lung5.913.926.5
    Colorectal6.512.412.1
    Other49.248.649.3

    “Other” refers to remaining primary types of cancer listed in International Classification of Diseases for

    Oncology-3. Included are all other invasive types and in situ for bladder.

    Data source: For cancer research investment: Canadian Cancer Research Alliance database.

    Data source for new cancer cases: Statistics Canada, Canadian Cancer Registry.

    Data source for cancer deaths: Statistics Canada, Vital Statistics Death Database.

    Source: CANSIM Table 103-0550 for 2012 cancer cases, CANSIM Table 102-0552 for 2011 cancer deaths.

  • Data specifications

    Data specifications

    Definition:

    1. Distribution of cancer-specific research funding for breast, colorectal, lung and prostate cancers
    2. Distribution of new cancer cases in Canada
    3. Distribution of cancer deaths in Canada

    Numerator:

    1. Investment: Amount of site-specific research investment (in dollars) for breast, prostate, lung, colorectal, or other cancers
    2. New cancer cases: Number of site-specific cases for breast, prostate, lung, colorectal, or other cancers
    3. Cancer deaths: Number of site-specific deaths from breast, prostate, lung, colorectal, or other cancers

    Denominator:

    1. Investment: Total amount of site-specific cancer research investment (in dollars)
    2. New cancer cases: Total number of new cancer cases
    3. Cancer deaths: Total number of cancer deaths

    Data source:

    1. Investment: Canadian Cancer Research Alliance, Canadian Cancer Research Survey
    2. New cases: Statistics Canada (CANSIM Table 103-0550), Canadian Cancer Registry
    3. Deaths: Statistics Canada (CANSIM Table 102-0552), Vital Statistics Death Database

    Measurement timeframe: 2013 (cancer research investment), 2012 (new cancer cases), 2011 (cancer deaths)

    Stratification variables: Disease site (breast, prostate, lung, colorectal, other)

    Notes:

    “Other” refers to the remaining primary types of cancer listed in ICD-O-3. Included are all other invasive types and in-situ for bladder.

  • Related indicators